ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport.
Liu B, Azfar M, Legchenko E, West JA, Martin S, Van den Haute C, Baekelandt V, Wharton J, Howard L, Wilkins MR, Vangheluwe P, Morrell NW, Upton PD.
Liu B, et al. Among authors: west ja.
Cardiovasc Res. 2024 May 29;120(7):756-768. doi: 10.1093/cvr/cvae068.
Cardiovasc Res. 2024.
PMID: 38626311
Free PMC article.